DPIIT recognised startup Government of India
Startup India
Eradicatus Infectus Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹9.15 Cr
▲ 1304% YoY
Net profit · FY 2025
₹4.8 Cr
Net margin 52.4%
EBITDA · FY 2025
₹6.47 Cr
EBITDA margin 70.8%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹9.8 Lakh
Satisfied ₹95.86 Lakh
Company age
7 yrs
Est. 2019
Employees · EPFO
8
Provident fund records
About Eradicatus Infectus Private Limited
Data last updated:
Eradicatus Infectus Private Limited is a private limited company based in New Delhi, Delhi, India, recognised as a startup by DPIIT. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 04 December 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U73100DL2019PTC358370. Its GSTIN is 06AAICG1096M1Z9 (Haryana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Preeti Tank and Anubhav Anusha.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at D – 34 3rd Floor, Anand Niketan, New Delhi, Delhi, India – 110021.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.15 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹4.8 Cr (net margin 52.4%) and EBITDA of ₹6.47 Cr (EBITDA margin 70.8%). Revenue has grown at a compounded annual rate (CAGR) of 40% over three years and 94% over five years.
The company has about 8 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
As per MCA filings, the company has open charges of ₹9.8 Lakh and satisfied charges of ₹95.86 Lakh on record. Court records list 6 cases involving the company, including 2 filed by the company and 4 filed against it; 2 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genestore.org.
Company details
CIN U73100DL2019PTC358370
Registration Number 358370
Incorporation Date 04 December 2019
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Key People
Preeti Tank Director Anubhav Anusha Director Recognitions & Rankings of Eradicatus Infectus
Contact details
Eradicatus Infectus Private Limited's registered office is in New Delhi, Delhi. Its website is genestore.org. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressD – 34 3rd Floor, Anand Niketan, New Delhi, Delhi, India – 110021
- IndustryPharma, Pharma Contract R&D
To see the full contact details of Eradicatus Infectus Private Limited, buy the company report.
Comprehensive company report
Eradicatus Infectus Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Eradicatus Infectus is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Eradicatus Infectus Private Limited, buy the company report.
Financials of Eradicatus Infectus Private Limited
FY 2024 filings availableEradicatus Infectus Private Limited reported revenue of ₹9.15 Cr (up 1304% YoY) for FY 2025.
Revenue · FY 2025
₹9.15 Cr ▲ 1304%
Net profit · FY 2025
₹4.8 Cr margin 52.4%
EBITDA · FY 2025
₹6.47 Cr margin 70.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
3 years · compounded
▼ 40%
5 years · compounded
▲ 94%
EBITDA CAGR growth
1 year
▲ 542%
3 years · compounded
▼ 4%
5 years · compounded
▲ 153%
Revenue has grown at a compounded annual rate (CAGR) of 94% over five years. EBITDA rose 542% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.47 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.8 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 70.8% | ||||
| Net Profit Margin | 52.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eradicatus Infectus Private Limited, buy the company report.
Board of directors of Eradicatus Infectus Private Limited
Eradicatus Infectus has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Preeti Tank | Director | 04 Dec 2019 | 6 Years 10 Months | Current |
| Anubhav Anusha Also directs: Franco Alliance Private Limited, Bawe Welfare Foundation, Pathstore DX RX India Private Limited and 2 more | Director | 18 Jul 2025 | 1 Years 3 Months | Current |
Auditor
Eradicatus Infectus Private Limited is audited by O.P. Bagla & Co. LLP for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| O.P. Bagla & Co. LLP | FY 2024 | 000018N/N500091 |
Shareholding
The shareholding of Eradicatus Infectus Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Eradicatus Infectus Private Limited, buy the company report.
Charges & borrowings
Open charges
₹9.8 Lakh
Satisfied charges
₹95.86 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Dec 2023 | 100849026 | Others | ₹9.8 Lakh | Open | |
| 26 Aug 2022 | 100606183 | Axis Bank Limited | ₹95.86 Lakh | Satisfied |
To see the full charge records of Eradicatus Infectus Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
Eradicatus Infectus Private Limited has 6 court cases on record: 2 filed by Eradicatus Infectus, 4 filed against it. 2 cases are pending and 4 are disposed.
Total cases
6
Filed by the company
2
Filed against the company
4
Pending
2
Disposed
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 5 | 3 | 2 |
| District courts | 1 | 1 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (O.M.P. (T) (COMM.)) | Filed against the company by Indigrid Technology Pvt Ltd | Disposed |
| High Court of Delhi | Court case (CRL.M.C.) | Filed by the company against Income Tax Office | Pending |
| High Court of Delhi | Tax appeal | Filed by the company against Deputy Commissioner of Income Tax, Circle 7(1) & Anr. | Pending |
| District court, South, Delhi | Court case (Ex.COMM - Award by Arb. Comm.) | Filed against the company by an individual | Disposed |
| High Court of Delhi | Court case (O.M.P.(MISC.)(COMM.)) | Filed against the company by an individual | Disposed |
To see the full case history of Eradicatus Infectus Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eradicatus Infectus Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Eradicatus Infectus has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
2
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Franco Alliance Private Limited | U85100DL2021PTC378228 | |
| Pathstore DX RX India Private Limited | U85300DL2022PTC396079 |
To see the full group structure of Eradicatus Infectus Private Limited, buy the company report.
Employees & EPFO
Eradicatus Infectus Private Limited has a workforce of 8 employees on its EPFO records as of Mar 25, 2025, across 1 active EPFO establishment.
Employee count
8
Active EPFO establishments
1
Employee growth
-33.33%
GST
Eradicatus Infectus has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAICG1096M1Z9 | Haryana | Active | 02 Feb 2021 |
To see the full GST registrations and return filing status of Eradicatus Infectus Private Limited, buy the company report.
Recent activity
Eradicatus Infectus Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Anubhav Anusha ceased to be Additional Director on 22 Sep 2025.
Ceased
Anubhav Anusha ceased to be Additional Director.
Appointed
Anubhav Anusha was appointed as Director.
Ceased
Manavi Anusha ceased to be Director.
AGM
Eradicatus Infectus Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Eradicatus Infectus Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge registered on 26 Aug 2022 via Charge ID 100606183 with Axis Bank Limited was fully satisfied on 15 Jan 2024.
Charges
A charge with Others amounted to Rs. 9.80 Lakh with Charge ID 100849026 was registered on 22 Dec 2023.
Charges
A charge with Axis Bank Limited amounted to Rs. 95.86 Lakh with Charge ID 100606183 was registered on 26 Aug 2022.
Appointed
Preeti Tank was appointed as Director.
Incorporation
04 Dec 2019
Eradicatus Infectus Private Limited was registered on 04 Dec 2019 with Roc Delhi & aged 6 years 10 months as per MCA records.
Frequently asked questions
Eradicatus Infectus is an active private limited company based in New Delhi, Delhi, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 04 December 2019 (7+ years old) and is registered under CIN U73100DL2019PTC358370.
Eradicatus Infectus has 2 current directors:
- Preeti Tank - Director
- Anubhav Anusha - Director
The latest financial statements of Eradicatus Infectus on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Eradicatus Infectus is 06AAICG1096M1Z9, registered in Haryana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Eradicatus Infectus is U73100DL2019PTC358370. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eradicatus Infectus has 6 court cases on record: 2 filed by the company and 4 filed against it. 2 are pending. Most are in the high courts.
Eradicatus Infectus was incorporated on 04 December 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Anubhav Anusha ceased to be Additional Director on 22 Sep 2025. Anubhav Anusha was appointed as Director on 18 Jul 2025. Manavi Anusha ceased to be Director on 18 Jul 2025. Eradicatus Infectus has 4 board changes on record in total.
Yes, Eradicatus Infectus is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Eradicatus Infectus can be reached through the website genestore.org. Its registered office is in New Delhi, Delhi, India.